{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:40:02Z","timestamp":1789875602417,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejogrb.2016.11.007","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T13:31:39Z","timestamp":1478871099000},"page":"188-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Misoprostol exposure during the first trimester of pregnancy: Is the malformation risk varying depending on the indication?"],"prefix":"10.1016","volume":"207","author":[{"given":"Marine","family":"Auffret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bernard-Phalippon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Dekemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Gervoise Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2016.11.007_bib0005","unstructured":"Misoprostol, Martindale, Pharmaceutical Press, London, 38th edition (2014)."},{"key":"10.1016\/j.ejogrb.2016.11.007_bib0010","series-title":"Interruption m\u00e9dicamenteuse de grossesse. Les protocoles \u00e0 respecter","author":"de Sant\u00e9","year":"2015"},{"key":"10.1016\/j.ejogrb.2016.11.007_bib0015","unstructured":"Coll\u00e8ge National des gyn\u00e9cologues et Obst\u00e9tricien de France (CNGOF), Interruption m\u00e9dicale de grossesse. Processus d\u00e9cisionnel et pris en charge (2008)."},{"issue":"Suppl. 1","key":"10.1016\/j.ejogrb.2016.11.007_bib0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1471-0528.2009.02329.x","article-title":"The use of misoprostol in obstetrics and gynaecology","volume":"116","author":"Elati","year":"2009","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2016.11.007_bib0025","unstructured":"Product information, Cytotec. G.D. Searle (2001)."},{"key":"10.1016\/j.ejogrb.2016.11.007_bib0030","article-title":"Developmental toxicity including teratogenicity of E1 prostaglandins in rabbits","author":"Clemens","year":"1997","journal-title":"Toxicol"},{"issue":"8","key":"10.1016\/j.ejogrb.2016.11.007_bib0035","first-page":"502","article-title":"First case of Moebius-Poland syndrome in child prenatally exposed to misoprostol","volume":"26","author":"Pachajoa","year":"2011","journal-title":"Neurol Barc Spain"},{"issue":"5","key":"10.1016\/j.ejogrb.2016.11.007_bib0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pediatrneurol.2010.05.026","article-title":"Moebius syndrome and holoprosencephaly following exposure to misoprostol","volume":"43","author":"Pirmez","year":"2010","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.ejogrb.2016.11.007_bib0045","first-page":"147","article-title":"Moebius syndrome due to the use of misoprostol. Case report","volume":"44","author":"S\u00e1nchez","year":"2003","journal-title":"Investig Cl\u00ednica"},{"issue":"6","key":"10.1016\/j.ejogrb.2016.11.007_bib0050","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1345\/aph.1K550","article-title":"M\u00f6bius syndrome in a neonate after mifepristone and misoprostol elective abortion failure","volume":"42","author":"Bos-Thompson","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.11.007_bib0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.1320470113","article-title":"Limb deficiency with or without M\u00f6bius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy","volume":"47","author":"Gonzalez","year":"1993","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.11.007_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00019605-199901000-00010","article-title":"Terminal transverse limb defects with tethering and omphalocele in a 17 week fetus following first trimester misoprostol exposure","volume":"8","author":"Genest","year":"1999","journal-title":"Clin Dysmorphol"},{"issue":"9116","key":"10.1016\/j.ejogrb.2016.11.007_bib0065","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(97)12363-7","article-title":"Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy","volume":"351","author":"Gonzalez","year":"1998","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"10.1016\/j.ejogrb.2016.11.007_bib0070","first-page":"226","article-title":"Misoprostol teratogenicity: a prospective study in Argentina","volume":"109","author":"Barbero","year":"2011","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.ejogrb.2016.11.007_bib0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.reprotox.2012.11.009","article-title":"Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study","volume":"36","author":"Vauzelle","year":"2013","journal-title":"Reprod Toxicol Elmsford N"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.11.007_bib0080","first-page":"31","article-title":"Terappel: description of a computerised database and examples of studies","volume":"69","author":"Vial","year":"2014","journal-title":"Th\u00e9rapie"},{"issue":"4","key":"10.1016\/j.ejogrb.2016.11.007_bib0085","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/pds.3749","article-title":"Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study","volume":"24","author":"Bellet","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.ejogrb.2016.11.007_bib0090","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/1471-0528.12147","article-title":"Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study","volume":"120","author":"Bernard","year":"2013","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2016.11.007_bib0095","unstructured":"EUROCAT website database, EUROCAT prevalence data tables, (Internet), Available from: http:\/\/www.eurocat-network.eu\/prenatalscreeninganddiagnosis\/generalinformation\/introduction."},{"issue":"6","key":"10.1016\/j.ejogrb.2016.11.007_bib0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0010-7824(03)00171-9","article-title":"Pharmacological properties of mifepristone: toxicology and safety in animal and human studies","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.11.007_bib0105","first-page":"19","article-title":"Evaluation of the teratogenic risks in gestations exposed to misoprostol","volume":"32","author":"Opaleye","year":"2010","journal-title":"Rev Bras Ginecol E Obstetr\u00edcia Rev Fed Bras Soc Ginecol E Obstetr\u00edcia"},{"issue":"2","key":"10.1016\/j.ejogrb.2016.11.007_bib0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0890-6238(98)00072-0","article-title":"Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study","volume":"13","author":"Sch\u00fcler","year":"1999","journal-title":"Reprod Toxicol Elmsford N"},{"issue":"4","key":"10.1016\/j.ejogrb.2016.11.007_bib0115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1471-0528.2000.tb13272.x","article-title":"Epidemiological assessment of misoprostol teratogenicity","volume":"107","author":"Orioli","year":"2000","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2016.11.007_bib0120","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1590\/S0102-311X2008000600025","article-title":"Exposure to misoprostol and hormones during pregnancy and risk of congenital anomalies","volume":"24","author":"Dal Pizzol","year":"2008","journal-title":"Cad Sa\u00fade P\u00fablica"},{"issue":"26","key":"10.1016\/j.ejogrb.2016.11.007_bib0125","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJM199806253382604","article-title":"Use of misoprostol during pregnancy and M\u00f6bius\u2019 syndrome in infants","volume":"338","author":"Pastuszak","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2016.11.007_bib0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1096-8628(20001211)95:4<302::AID-AJMG2>3.0.CO;2-B","article-title":"Prenatal exposure to misoprostol and vascular disruption defects: a case-control study","volume":"95","author":"Vargas","year":"2000","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1016\/j.ejogrb.2016.11.007_bib0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/1099-1557(200009\/10)9:5<401::AID-PDS527>3.0.CO;2-1","article-title":"Misoprostol and congenital anomalies","volume":"9","author":"Brasil","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151631020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151631020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:39:32Z","timestamp":1759556372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151631020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":27,"alternative-id":["S030121151631020X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.11.007","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Misoprostol exposure during the first trimester of pregnancy: Is the malformation risk varying depending on the indication?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}